[chamada] National Institutes of Health (NIH) – Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01)
The Funding Opportunity Announcement (FOA) invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies.
R01: October 05, 2017.
Letter of Intent Due Date(s):
30 days prior to the application due date.
Data de expiração:
September 8, 2019.
Mais informações no site.